Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion type Assertion NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_head.
- NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion description "[Among samples obtained from patients with stomach cancer, methylation was observed in both the neoplastic and the corresponding non-neoplastic gastric epithelia; 43% (40/93) and 73% (68/93) for DAP-kinase, and 45% (42/93) and 8% (7/93) for RUNX3, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_provenance.
- NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion evidence source_evidence_literature NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_provenance.
- NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion SIO_000772 12824905 NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_provenance.
- NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion wasDerivedFrom befree-20140225 NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_provenance.
- NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_assertion wasGeneratedBy ECO_0000203 NP614843.RAJr0Nkf4vZrMMmYSQ-kwpVYHCGSNC_zDcduWpRWiVJvo130_provenance.